PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Medicine, Primary Care and Population Health, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Quality, Patient Safety and Clinical Effectiveness, Stanford Health Care, Stanford, California, USA.\', \'Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, USA.\', \'Workforce Health and Wellness, Stanford University School of Medicine, Stanford, California, USA.\', \'Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab554
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34137815
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all